Skip to main content
Log in

Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED III

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

In a multi-center trial, gadolinium enhanced magnetic resonance angiography (MRA) for diagnosis of acute pulmonary embolism (PE) had a high rate of technically inadequate images. Accordingly, we evaluated the reasons for poor quality MRA of the pulmonary arteries in these patients. We performed a retrospective analysis of the data collected in the PIOPED III study. We assessed the relationship to the proportion of examinations deemed “uninterpretable” by central readers to the clinical centers, MR equipment platform and vendors, degree of vascular opacification in different orders of pulmonary arteries; type, frequency and severity of image artifacts; patient co-morbidities, symptoms and signs; and reader characteristics. Centers, MR equipment vendor and platform, degree of vascular opacification, and motion artifacts influenced the likelihood of central reader determinations that images were “uninterpretable”. Neither the reader nor patient characteristics (age, body mass index, respiratory rate, heart rate) correlated with the likelihood of determining examinations “uninterpretable”. Vascular opacification and motion artifact are the principal factors influencing MRA interpretability. Some centers obtain better images more consistently, but the reasons for differences between centers are unclear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stein PD, Chenevert TL, Fowler SE, et al. for the PIOPED III Investigators (2010) Gadolinium enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Int Med 152:434–443

    Google Scholar 

  2. Fisher L, van Belle G (1993) Biostatistics: a methodology for the health sciences. New York, Wiley, p 206

    Google Scholar 

  3. Gibbons JD, Chakraborti S (1992) Nonparametric statistical inference. Marcel Dekker, Inc., 3rd edn. New York, 295

  4. Gibbons JD, Chakraborti S (1992) Nonparametric statistical inference. Marcel Dekker, Inc., 3rd edn. New York, 264

  5. Abujudeh HH, Kaewlai R, Farsad K, Orr E, Gilman M, Shepard JO (2009) Computed tomography pulmonary angiography: an assessment of the radiology report. Acad Radiol 16:1309–1315

    Article  PubMed  Google Scholar 

  6. Hadizadeh DR, Gieseke J, Lohmaier SH et al (2008) Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA. Radiology 249:701–711

    Article  PubMed  Google Scholar 

  7. Woodard PK, Chenevert TL, Sostman HD, Jablonski KA, Stein PD, Goodman LR, Londy FJ, Narra V, Hales CA, Hull RD, Tapson VF, Weg JG (2011) Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine. Int J Cardiovasc Imaging. doi:10.1007/s10554-011-9821-6

  8. Loubeyre P, Revel D, Douek P et al (1994) Dynamic contrast-enhanced MR angiography of pulmonary embolism: comparison with pulmonary angiography. AJR Am J Roentgenol 162:1035–1039

    PubMed  CAS  Google Scholar 

  9. Ohno Y, Higashino T, Takenaka D et al (2004) MR angiography with sensitivity encoding (SENSE) for suspected pulmonary embolism: comparison with MDCT and ventilation-perfusion scintigraphy. AJR Am J Roentgenol 183:91–98

    PubMed  Google Scholar 

  10. Ersoy H, Goldhaber SZ, Cai T et al (2007) Time-resolved MR angiography: a primary screening examination of patients with suspected pulmonary embolism and contraindications to administration of iodinated contrast material. AJR Am J Roentgenol 188:1246–1254

    Article  PubMed  Google Scholar 

  11. Blum A, Bellou A, Guillemin F, Douek P, Laprevope-Heully MC, Wahl D, GENEPI study group (2005) Performance of magnetic resonance angiography in suspected acute pulmonary embolism. Thromb Haemost 93:503–511

    PubMed  CAS  Google Scholar 

  12. Goodman LR (2005) Small pulmonary emboli: what do we know? (Editorial) Radiology 234:654–658

    PubMed  Google Scholar 

  13. Stein PD, Henry JW (1997) Prevalence of acute pulmonary embolism in central and subsegmental pulmonary arteries and relation to probability interpretation of ventilation/perfusion lung scans. Chest 11:1246–1248

    Article  Google Scholar 

  14. Stein PD, Fowler SE, Goodman LR, et al. for the PIOPED II Investigators (2006) Multidetector computed tomography for acute pulmonary embolism. N Eng J Med 354:2317–2327

    Google Scholar 

  15. Quinn MF, Lundell CJ, Klotz TA et al (1987) Reliability of selective pulmonary arteriography in the diagnosis of pulmonary embolism. Am J Roent 149:469–471

    CAS  Google Scholar 

  16. Krishnam MS, Tomasian A, Deshpande V et al (2008) Noncontrast 3D steady-state free-precession magnetic resonance angiography of the whole chest using nonselective radiofrequency excitation over a large field of view: comparison with single-phase 3D contrast-enhanced magnetic resonance angiography. Invest Radiol 43:411–420

    Article  PubMed  Google Scholar 

  17. Wells PS, Anderson DR, Rodger M et al (2001) Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med 135:98–107

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by Grants HL081593, HL177150, HL077149, HL077151, HL077154, HL081594, HL077358, HL077155, and HL077153 from the U.S. Department of Health and Human Services, Public Health Services, National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Conflict of interest

Dr. Woodard received research support from GE Healthcare and Siemens Medical Systems.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pamela K. Woodard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dirk Sostman, H., Jablonski, K.A., Woodard, P.K. et al. Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED III. Int J Cardiovasc Imaging 28, 303–312 (2012). https://doi.org/10.1007/s10554-011-9820-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-011-9820-7

Keywords

Navigation